When you need confidence in your cold chain… Trust Cryoport

Early approvals of upcoming cell therapies have moved up manufacturing timelines for many firms in the biotech space. This blaze of approvals has been ignited by positive early clinical trial data, and now manufacturers are facing the substantial logistical challenges of scaling their products into the commercial stage. 

The human genome and diseases interact in mysterious ways. Along with external factors, these interactions can affect who gets an illness, how serious it gets, at what rate, how the patient responds to treatments and the longer prognosis.